Imagining a TB-free world amidst resurgence during COVID-19 pandemic.
Favorite
2022
When working with patients who prefer to communicate in Cantonese, the flashcards can be used to monitor side effects and adverse reactions from TB medications.
Favorite
Non-U.S.-born persons
Persons With LTBI
Persons with TB
2021
When working with patients who prefer to communicate in Cantonese, the flashcards can be used to monitor side effects and adverse reactions from TB medications.
Favorite
Non-U.S.-born persons
Persons With LTBI
Persons with TB
2021
When working with patients who prefer to communicate in Mandarin, the flashcards can be used to monitor side effects and adverse reactions from TB medications.
Favorite
Non-U.S.-born persons
Persons With LTBI
Persons with TB
2021
When working with patients who prefer to communicate in Somali, the flashcards can be used to monitor side effects and adverse reactions from TB medications.
Favorite
Non-U.S.-born persons
Persons With LTBI
Persons with TB
2021
When working with patients who prefer to communicate in Spanish, the flashcards can be used to monitor side effects and adverse reactions from TB medications.
Favorite
Non-U.S.-born persons
Persons With LTBI
Persons with TB
2021
When working with patients who prefer to communicate in Vietnamese, the flashcards can be used to monitor side effects and adverse reactions from TB medications.
Favorite
Non-U.S.-born persons
Persons With LTBI
Persons with TB
2021
When working with patients who prefer to communicate in Dari, the flashcards can be used to monitor side effects and adverse reactions from TB medications.
Favorite
Non-U.S.-born persons
Persons With LTBI
Persons with TB
2021
When working with patients who prefer to communicate in Pashto, the flashcards can be used to monitor side effects and adverse reactions from TB medications.
Favorite
Non-U.S.-born persons
Persons With LTBI
Persons with TB
2021
How to give a sample for testing for pulmonary tuberculosis. Most diagnostic tests for TB examine sputum coughed from the lungs. The lack of access to TB diagnosis is a major barrier to controlling TB which kills nearly 2 million people every year. New sensitive tests that are affordable and that can be used in a low tech environment are urgently needed.
Favorite
Persons With LTBI
2010
The purpose of this document is to highlight cases in which Advocacy, Communication and Social Mobilization (ACSM) interventions have contributed to a positive outcome of tuberculosis (TB) control activities directed to a range of audiences and settings. It is intended for on-the-ground stakeholders who are interested in successfully integrating ACSM strategies and activities into TB control programming, as well as for decision-makers who can provide greater political and financial support for ACSM activities at the national, sub-national and international level.
Favorite
International Agencies
Managers and Supervisors
Outreach Workers
2010
This document sets out a 10-year strategic framework for advocacy, communications, and social mobilization activities and is a key supporting document to the Stop TB Partnership’s Global Plan to Stop TB 2006–2015.
Favorite
Community Leaders
International Agencies
2006
This book is the first title in Wiley-Blackwell's new 'Infection Biology Series'. Early chapters focus on immunology and the problems facing vaccination strategies for both diseases. Later chapters deal with some of the most threatening consequences of this co-infection, such as the emergence of drug resistant TB.
Favorite
International Agencies
Lab Personnel
2009
The AIDSFree Guidance Database provides national HIV testing and treatment guidance and HIV/TB co-infection treatment guidance from many different countries from around the world.
Favorite
International Agencies
2016
This video addresses the ongoing challenge of tuberculosis (TB) in Alaska, which has the highest TB rate in the United States. It emphasizes that TB can affect anyone and underscores the importance of awareness, testing, and treatment to help end TB in the state.
Favorite
At Risk Persons
General Public
Health Educators/Communicators
2025
This 90-minute webinar was held for clinicians and others who provide services to TB patients or persons at risk for TB with significant alcohol and/or tobacco use.
Favorite
Nurses
Physicians
2011
This guide is designed to explain the safety and efficacy of bedaquiline. It also describes what you as an activist can do to help ensure access, fair pricing and further research. The guide provides messages that regulatory authorities need to hear to prepare for bedaquiline and other new TB drugs...
Favorite
2018
This guide details safety, efficacy, and access information on rifapentine. The guide also provides activists with the evidence and content needed to advocate for rifapentine to be available, accessible, and affordable to those who may need it.
Favorite
2019
The guide details messaging and strategies to help advocates and activists ensure that the LAM test is made available in-country.
Favorite
International Agencies
Policy Makers
2020
This guide details 2020 updates to the WHO guidelines about the global standard of care for drug-resistant TB. The guide also includes messaging and strategies that can be used to advocate for WHO-recommended regimens.
Favorite
International Agencies
Policy Makers
2020
